About us

We bring together scientists, clinicians, patients, entrepreneurs, and investors to fund cutting–edge scientific innovations so that we can accelerate research and development (R&D) and bring scientific breakthroughs to the clinic.

We are democratizing how research is funded and how the resulting intellectual property (IP) is owned. To do so, we are pioneering the use of Web3 technologies and generative AI for biomedical and life sciences research and commercialization.

Who do we serve and what do we offer?

Scientists /Academics/ Physicians can apply for funding, while also gaining the right to own a percentage of the IP they produce through their work.

Patients and patient advocacy groups can help fund their potential cure, and also own all or part of the IP resulting from the projects they fund or collaborate on.

Retail and institutional investors can invest in pre-screened top-tier science projects and companies and own a diversified biotech IP portfolio. Investors will have a trusted place to invest by clinical stage into any indication or stage.

University tech transfer offices and admins can outsource management and commercialization sales and licensing of their IP portfolio, minimizing costs and maximizing benefits. We welcome US and international inquiries.

Citizen scientists, the bio-curious, or hobbyists can invest into projects they believe in using $BIO. Or they can propose starting a research and funding program in an area affecting them or a family member. There may be other ways to earn tokens for work performed and rewarded by bounties.

Team

  • Mark Stoner, CEO & Founder BioCrowd, Inc.

    Mark is a senior business development leader with over 30 years experience in US and international sales and marketing for professional services firms, including Accenture and PriceWaterhouseCoopers. Top-performing consulting and technology solutions executive in closing major sales and revenue initiatives. Global Alliance Director of a blockchain development agency that launched 25 Initial Coin Offerings (ICO's) that raised over $200 million.

    He served as a registered lobbyist for the British Government creating foreign direct investment to the UK among other roles..

  • Jeffrey Koury, Operations Director

    PhD in Biomedical Science with a particular focus on neuroinflammation and virology. 1.5+ years of experience in Decentralized Science and DAO Management/Operations.

  • Angelo Masullo, Finance Director

    Web3, financial modeling, distributed ledger technology (DLT)

  • Prentice Tom, MD, Senior Advisor & Shareholder

    ndustry executive leading nationally recognized innovations in care delivery. Former CIO at Vituity, Harvard Medical School, Stanford Medical School.

Advisors

Robyn Leary

PhD Molecular Genetics, Biotech Inventor/Scientist, Drug and Clinical Development, Clinical Research, Medical Affairs, Angel Investor.

Shahed Iqbal

Senior Director and Head, Molecular Epidemiology, Biomarker Sciences at Gilead Sciences.

Edye Edens

Attorney with Experience in Health Law, IRB & FDA, Research Integrity, Contracts, CRO Operations and Compliance.

Cyrus Sarraf

Coinbase, Google, Crypto Team at Robinhood. UX and product strategist in FinTech, Crypto & Web3.

Amer Mujkanovic, MD

Researcher, and Biostatistician, PhD, Clinical Research Fellow, Mayo Clinic, Fulbright Scholarship Alumni.

Steve Goldsmith

Healthcare Marketing, Investor, Former VP of Marketing for MedTech Company.

Ajeeth Rao

Co-Founder & CEO at Inventico Creative, Providing Data Driven AI & ML Solutions for Pharma, Biotech, CRO, Healthcare & MedTech.

Dennis Takasugi

Medical Diagnostics and Biopharmaceutical Commercialization. In-licensing late stage diagnostic assets.

Apply for Funding

We fund innovative translational research from startups as well as academics.

Apply for Funding

Become an Expert

Contribute to a global network in biology as well as intellectual property (IP) law and capital markets.

Become an Expert

How it Works

After vetting your experience, you will be given a contributor NFT associated with your SubDAO and expertise type.

How it Works